Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$353.37
Market cap
$134.66B
P/E Ratio
38.96
Dividend/share
$3.2
EPS
$9.07
Enterprise value
$145.01B
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems;
Highlights
SYK's net income is up by 27% year-on-year and by 2.6% since the previous quarter
Stryker's EPS has increased by 27% YoY and by 2.5% from the previous quarter
SYK's quick ratio is up by 13% YoY but it is down by 4.7% from the previous quarter
Key stats
What are the main financial stats of SYK
Market
Valuations
Earnings
Shares outstanding
381.08M
Market cap
$134.66B
Enterprise value
$145.01B
Price to earnings (P/E)
38.96
Price to book (P/B)
6.81
Price to sales (P/S)
6.29
EV/EBIT
36.11
EV/EBITDA
32.77
EV/Sales
6.78
Revenue
$21.39B
EBIT
$4.02B
EBITDA
$4.43B
Free cash flow
$2.8B
Per share
Balance sheet
Liquidity
EPS
$9.07
Free cash flow per share
$7.36
Book value per share
$51.88
Revenue per share
$56.14
TBVPS
$50.81
Total assets
$39.13B
Total liabilities
$19.37B
Debt
$12.22B
Equity
$19.76B
Working capital
$4.72B
Debt to equity
0.62
Current ratio
1.68
Quick ratio
0.81
Net debt/EBITDA
2.34
Margins
Efficiency
Dividend
EBITDA margin
20.7%
Gross margin
63.6%
Net margin
16.1%
Operating margin
19.7%
Return on assets
8.8%
Return on equity
18.3%
Return on invested capital
17.9%
Return on capital employed
12.5%
Return on sales
18.8%
Dividend yield
0.91%
DPS
$3.2
Payout ratio
35.3%
SYK stock price
How has the Stryker stock price performed over time
Intraday
-0.17%
1 week
0.5%
1 month
-3.2%
1 year
28.76%
YTD
18%
QTD
-2.18%
Financial performance
How have Stryker's revenue and profit performed over time
Revenue
$21.39B
Gross profit
$13.61B
Operating income
$4.21B
Net income
$3.45B
Gross margin
63.6%
Net margin
16.1%
SYK's net income is up by 27% year-on-year and by 2.6% since the previous quarter
The operating income has grown by 27% year-on-year and by 2.1% since the previous quarter
SYK's net margin is up by 16% YoY
Stryker's operating margin has increased by 15% YoY
Growth
What is Stryker's growth rate over time
Valuation
What is Stryker stock price valuation
P/E
38.96
P/B
6.81
P/S
6.29
EV/EBIT
36.11
EV/EBITDA
32.77
EV/Sales
6.78
Stryker's EPS has increased by 27% YoY and by 2.5% from the previous quarter
SYK's P/E is 10% below its 5-year quarterly average of 43.1
SYK's equity is up by 14% year-on-year and by 3.1% since the previous quarter
SYK's P/B is 10% above its 5-year quarterly average of 6.2 and 6% above its last 4 quarters average of 6.4
The stock's price to sales (P/S) is 14% more than its 5-year quarterly average of 5.5 and 8% more than its last 4 quarters average of 5.8
The company's revenue rose by 10% YoY and by 2% QoQ
Efficiency
How efficient is Stryker business performance
Stryker's ROIC has increased by 27% YoY
The ROA has grown by 19% YoY
Stryker's ROS has increased by 16% YoY
The ROE rose by 14% YoY
Dividends
What is SYK's dividend history
DPS
$3.2
Dividend yield
0.91%
Payout ratio
35.3%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Stryker financials performed over time
The total assets is 102% greater than the total liabilities
SYK's quick ratio is up by 13% YoY but it is down by 4.7% from the previous quarter
The current ratio has grown by 9% year-on-year
SYK's debt is 38% less than its equity
The debt to equity has contracted by 17% YoY and by 7% from the previous quarter
SYK's equity is up by 14% year-on-year and by 3.1% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.